Zonghao You

Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer.

ZNF263-NuRD-mediated repression of STAT1 curtails MHC-I antigen presentation and IFN-γ efficacy in prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 21, 2026

HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine.

HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine.

Journal: Cell reports

Published: December 16, 2025

A molecular engineered NIR-II fluorescence agent with enhanced radiative and non-radiative decay for precision prostate cancer bone metastasis theranostics.

A molecular engineered NIR-II fluorescence agent with enhanced radiative and non-radiative decay for precision prostate cancer bone metastasis theranostics.

Journal: Materials today. Bio

Published: October 27, 2025

ETS Homologous Factor Drives Endothelial Dysfunction in Diabetes-Related Erectile Dysfunction via Regulating SPRY1 Ubiquitination and NOS3 Autophagy.

ETS Homologous Factor Drives Endothelial Dysfunction in Diabetes-Related Erectile Dysfunction via Regulating SPRY1 Ubiquitination and NOS3 Autophagy.

Journal: The world journal of men's health

Published: March 18, 2025

AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer.

AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer.

Journal: Scientific reports

Published: October 17, 2024

Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.

Matrix Metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.

Journal: Biology direct

Published: September 24, 2024

LINC00908 Inactivates Wnt/β-Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2.

LINC00908 Inactivates Wnt/β-Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2.

Journal: Cancer medicine

Published: August 28, 2023

YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.

YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.

Journal: Journal for immunotherapy of cancer

Published: March 27, 2023

Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.

Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.

Journal: Science advances

Published: October 05, 2022

Transgenic construction and functional miRNA analysis identify the role of miR-7 in prostate cancer suppression.

Transgenic construction and functional miRNA analysis identify the role of miR-7 in prostate cancer suppression.

Journal: Oncogene

Published: June 18, 2022

Associations between exposure to different heavy metals and self-reported erectile dysfunction: a population-based study using data from the 2001-2004 National Health and Nutrition Examination Survey.

Associations between exposure to different heavy metals and self-reported erectile dysfunction: a population-based study using data from the 2001-2004 National Health and Nutrition Examination Survey.

Journal: Environmental science and pollution research international

Published: November 29, 2021

Association of Long Non-Coding RNA MEG3 Polymorphisms and Risk of Prostate Cancer in Chinese Han Population.

Association of Long Non-Coding RNA MEG3 Polymorphisms and Risk of Prostate Cancer in Chinese Han Population.

Journal: Urology journal

Published: August 23, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026